TWI817977B - 活化腫瘤浸潤淋巴細胞之方法 - Google Patents

活化腫瘤浸潤淋巴細胞之方法 Download PDF

Info

Publication number
TWI817977B
TWI817977B TW108100871A TW108100871A TWI817977B TW I817977 B TWI817977 B TW I817977B TW 108100871 A TW108100871 A TW 108100871A TW 108100871 A TW108100871 A TW 108100871A TW I817977 B TWI817977 B TW I817977B
Authority
TW
Taiwan
Prior art keywords
tumor
cancer
fermentation
tils
composition
Prior art date
Application number
TW108100871A
Other languages
English (en)
Chinese (zh)
Other versions
TW201938181A (zh
Inventor
路孔明
郭明良
楊璦禎
Original Assignee
中天生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中天生物科技股份有限公司 filed Critical 中天生物科技股份有限公司
Publication of TW201938181A publication Critical patent/TW201938181A/zh
Application granted granted Critical
Publication of TWI817977B publication Critical patent/TWI817977B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
TW108100871A 2018-01-09 2019-01-09 活化腫瘤浸潤淋巴細胞之方法 TWI817977B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862615300P 2018-01-09 2018-01-09
US62/615,300 2018-01-09

Publications (2)

Publication Number Publication Date
TW201938181A TW201938181A (zh) 2019-10-01
TWI817977B true TWI817977B (zh) 2023-10-11

Family

ID=67139037

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108100871A TWI817977B (zh) 2018-01-09 2019-01-09 活化腫瘤浸潤淋巴細胞之方法

Country Status (6)

Country Link
US (1) US11179425B2 (cg-RX-API-DMAC7.html)
EP (2) EP3737395A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021517587A (cg-RX-API-DMAC7.html)
CN (1) CN111655272A (cg-RX-API-DMAC7.html)
TW (1) TWI817977B (cg-RX-API-DMAC7.html)
WO (1) WO2019137384A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119868398A (zh) * 2018-06-14 2025-04-25 株式会社明治 用于促进免疫检查点抑制疗法的组合物
JP7856975B2 (ja) 2022-09-12 2026-05-12 賢一郎 蓮見 抗腫瘍免疫応答増強剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017167213A1 (en) * 2016-03-30 2017-10-05 Microbio Co., Ltd. Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
DE60134386D1 (de) 2001-03-21 2008-07-24 Microbio Co Ltd Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt
JP2003335695A (ja) * 2002-05-17 2003-11-25 Nippon Bio Kk 大豆発酵物よりなる免疫増強剤、抗腫瘍剤、加工食品および大豆発酵物の製造方法
TWI252759B (en) 2002-07-05 2006-04-11 Microbio Co Ltd Method of using fermented glycine max (L.) extract for enhancing natural killer cell activity
CN100352459C (zh) 2004-07-15 2007-12-05 中天生物科技股份有限公司 发酵大豆萃取液在制备药物中的应用
SG187554A1 (en) 2010-07-20 2013-03-28 Microbio Co Ltd Use of a fermented soy extract for manufacture of a prebiotic composition
EP2659898B1 (en) * 2010-12-28 2018-03-07 Kirin Holdings Kabushiki Kaisha Use of lactococcus bacteria in the treatment or prevention of viral infections
JP2015051970A (ja) 2013-09-06 2015-03-19 マイクロバイオ カンパニー, リミテッド 化学療法を受けているがん患者向けのアジュバントを製造するための組成物
EA201690912A1 (ru) * 2013-11-05 2016-10-31 Когнейт Биосервисис, Инк. Комбинации ингибиторов контрольных точек и терапевтических средств для лечения рака
EP3228701A1 (en) * 2016-04-05 2017-10-11 Fundación Centro Nacional de Investigaciones Oncológicas Carlos III Method for preparing lymphocytes capable of infiltrating a solid tumor, lymphocytes obtainable by said method and uses thereof
CN112779217B (zh) * 2021-03-29 2023-04-11 复旦大学附属中山医院 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017167213A1 (en) * 2016-03-30 2017-10-05 Microbio Co., Ltd. Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota

Also Published As

Publication number Publication date
EP3737395A4 (en) 2021-09-29
US11179425B2 (en) 2021-11-23
TW201938181A (zh) 2019-10-01
CN111655272A (zh) 2020-09-11
EP4755455A2 (en) 2026-06-10
JP2021517587A (ja) 2021-07-26
EP3737395A1 (en) 2020-11-18
US20190209623A1 (en) 2019-07-11
JP2024050573A (ja) 2024-04-10
WO2019137384A1 (en) 2019-07-18

Similar Documents

Publication Publication Date Title
CN110496140B (zh) 脆弱拟杆菌或阿克曼粘细菌在制备用于预防或治疗肿瘤的药物中的应用
US12186350B2 (en) Antitumor effect potentiator
JP7594826B2 (ja) ラクトバチルス・プランタルムgb104株及びそれを含むがんの予防又は処置のための組成物
CN109966320B (zh) 凝结芽孢杆菌在制备诱导抗肿瘤免疫及免疫检查点抑制剂增敏制剂中的应用
EP3746121A1 (en) Compositions and methods for treating immune disorders using lachnospiraceae bacteria
CN114540229A (zh) 一种增强免疫检查点抑制剂治疗效应的副干酪乳杆菌株及其应用
CN109771445B (zh) 酪酸梭菌在制备诱导抗肿瘤免疫及免疫检查点抑制剂增敏制剂中的应用
JP2024050573A (ja) 腫瘍浸潤リンパ球(tils)を活性化する方法
CN117987297B (zh) 一株肠道菌及其在抗肿瘤免疫治疗中的应用
CN116782948A (zh) 包含长双歧杆菌rapo(kctc13773bp)的用于预防或治疗癌症的组合物
WO2024140860A1 (zh) 克里斯滕森菌或包含其的组合物在预防或治疗肿瘤中的用途以及包含其的药物
CN115806893B (zh) 普通拟杆菌及其组合物在辅助癌症免疫治疗中的应用
CN112334141A (zh) 用于促进免疫检查点抑制疗法的组合物
CN117503802A (zh) Ac菌在抗肿瘤免疫治疗中的应用
Wei et al. Dietary fungi in cancer immunotherapy: from the perspective of gut microbiota
KR102881730B1 (ko) 항암 활성을 갖는 신규 박테리아 균주 및 이를 이용한 암의 완화, 예방 또는 치료용 조성물
CN110448681B (zh) 一种用于恶性肿瘤免疫治疗的联合药物
CN111450124B (zh) 阿克曼粘菌或普氏菌在增加肿瘤微环境γδT细胞积累并增强抗肿瘤免疫功能药物中的应用
CN115747097B (zh) 一种Bifidobacterium bifidum菌株及其在肿瘤辅助治疗中的应用
JP6088648B2 (ja) 貪食細胞へ物質を送達する担体
CN109432116A (zh) 黄芪皂苷ⅲ在制备肿瘤免疫治疗药物中的用途
JP2024025452A (ja) 機能的免疫賦活乳酸菌
KR20240123764A (ko) 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물
KR20230121536A (ko) 락토바실러스 플란타룸 균주 및 항암제를 포함하는 병용 요법을 이용한 암 예방 또는 치료용 조성물
KR20240040601A (ko) 락토바실러스 플란타룸 균주를 포함하는 장내 대사산물 조성의 개선을 위한 조성물